Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection

Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Stylianou, E, Betts, G, Dicks, M, Griffiths, K, Poyntz, H, Mcshane, H
التنسيق:	Conference item
منشور في:	2011

مواد مشابهة

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection
حسب: Betts, G, وآخرون
منشور في: (2012)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
حسب: Griffiths, K, وآخرون
منشور في: (2013)

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.
حسب: Gareth Betts, وآخرون
منشور في: (2012-01-01)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
حسب: Griffiths, K, وآخرون
منشور في: (2011)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
حسب: Stylianou, E, وآخرون
منشور في: (2015)

Evaluation of immunological mechanisms induced by Mycobacterium avium exposure and the effect upon pre-existing BCG immunity
حسب: Poyntz, H, وآخرون
منشور في: (2011)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
حسب: Poyntz, H, وآخرون
منشور في: (2014)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
حسب: Marsay, L, وآخرون
منشور في: (2013)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis
حسب: Poyntz, H, وآخرون
منشور في: (2014)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
حسب: Marsay, L, وآخرون
منشور في: (2013)

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis
حسب: Christopher J. De Voss, وآخرون
منشور في: (2025-02-01)

Viral vector delivery of Env trimer immunogens
حسب: Parks CL, وآخرون
منشور في: (2012-09-01)

Uncovering the mechanisms of adenovirus vector immunogenicity
حسب: Dicks, M, وآخرون
منشور في: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
حسب: Meyer, J, وآخرون
منشور في: (2013)

Viral vectors as vaccine platforms: from immunogenicity to impact
حسب: Ewer (nee Russell), K, وآخرون
منشور في: (2016)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
حسب: Meyer, J, وآخرون
منشور في: (2013)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
حسب: Biswas, S, وآخرون
منشور في: (2011)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
حسب: Poyntz, HC
منشور في: (2012)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
حسب: Mcshane, H, وآخرون
منشور في: (2001)

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.
حسب: Rowland, R, وآخرون
منشور في: (2013)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
حسب: Sumi Biswas, وآخرون
منشور في: (2011-01-01)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
حسب: Dicks, M, وآخرون
منشور في: (2011)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
حسب: Sushmita Kumari, وآخرون
منشور في: (2022-08-01)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-riming and boosting with adenovirus or protein based vaccines
حسب: Dean, G, وآخرون
منشور في: (2014)

Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against Chikungunya virus
حسب: López-Camacho, C, وآخرون
منشور في: (2019)

Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19
حسب: Aiquan Chang, وآخرون
منشور في: (2022-02-01)

Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus
حسب: César López-Camacho, وآخرون
منشور في: (2019-04-01)

Protection by Persuasion: International Cooperation in the Refugee Regime
حسب: Betts, A
منشور في: (2010)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
حسب: Dean, G, وآخرون
منشور في: (2014)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
حسب: Dicks, M, وآخرون
منشور في: (2012)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
حسب: Vordermeier, H, وآخرون
منشور في: (2009)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
حسب: Sander, C, وآخرون
منشور في: (2009)

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.
حسب: White, A, وآخرون
منشور في: (2013)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
حسب: Vordermeier, H, وآخرون
منشور في: (2011)

Immunogenicity and protective efficacy of inactivated coxsackievirus B4 viral particles
حسب: Tingfeng Wang, وآخرون
منشور في: (2024-12-01)

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
حسب: Goonetilleke, N, وآخرون
منشور في: (2003)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
حسب: Stylianou, E, وآخرون
منشور في: (2019)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
حسب: Dulce Mata-Espinosa, وآخرون
منشور في: (2023-10-01)

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
حسب: Brookes, R, وآخرون
منشور في: (2008)

Evaluation of Duration of Immunogenicity and Protective Efficacy of Improved Influenza Viral Vector–Based Brucella abortus Vaccine Against Brucella melitensis Infection in Sheep and Goats
حسب: Aigerim Mailybayeva, وآخرون
منشور في: (2020-02-01)